How should we approach the treatment of progressive fibrosing ILDs? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019
Gender differences in bronchiectasis: a real issue? Source: Breathe, 14 (2) 108; 10.1183/20734735.000218 Year: 2018
Similarities and links between IPF and cancer: biologic considerations Source: Research Seminar 2015 Year: 2015
Asthma and COPD: similarities and differences in pathogenesis Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Pathogenetic mechanisms common to disease progression in fibrotic ILDs: the yang of pathogenetic thinking Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections Source: Eur Respir J 2001; 18: 101S-106S Year: 2001
The current classification of the idiopathic interstitial pneumonias: has it advanced pathogenetic understanding Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010
Personalised pathogenetic pathways in fibrotic ILDs: the yin of pathogenetic thinking Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019
The pathogenesis of IPF: what is the latest paradigm? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019
Similarities and differences in inflammatory mechanisms of asthma and COPD Source: Breathe 2011; 7: 229-238 Year: 2011
Intermediate-onset asthma: similarities and differences with early and late-onset Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
The progressive fibrotic phenotype in fibrotic ILDs: the critical importance of observed disease behaviour Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019
IPF: a distinct clinical entity? Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017
Fibrosing interstitial lung diseases: knowns and unknowns Source: Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018 Year: 2019
Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women Source: Eur Respir Rev, 31 (163) 210100; 10.1183/16000617.0100-2021 Year: 2022
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020
Interstitial lung diseases (ILDs) secondary to other conditions: common biology, epidemiology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020